Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study
Part of paid clinical trials in Cincinnati, Ohio.
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study ID
- NCT06305078
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 11 Years - 15 Years
- Healthy Volunteers
- Not accepted
Interventions
- Personalized ADHD Medication Experiment — OTHERAll parent/adolescent dyads will select and complete a medication experiment.
Study Details
The primary goal of the project is to test personalized medication experiments to inform decisions about future medication use. Our central hypothesis is that our intervention will lead to within subject increases in adolescent involvement in decision making and decreases in uncertainty about future medication use. The investigators view this open label trial as a pilot study to test the feasibility, acceptability, and preliminary efficacy of the medication experiment intervention and therefore warrants further testing in a future larger trial.
Key Dates
- Start date
- Nov 10, 2023
- Status verified
- Feb 2026
- Primary completion
- May 1, 2025
- Completion
- Nov 1, 2025
Study Design
- Enrollment
- 31 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: InterventionAll will choose one of five medication experiment options to complete.
Primary Outcome Measure
Decision Making Involvement Scale [Parent Seek] - Reported by Child [ Time Frame: The investigators will reference the Decision-Making Involvement interview guide to collect this measure at (pre) study visit 1 and the stand-alone version (post) 4-12 weeks later at study visit 2. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45220 | - |
Find similar trials in Cincinnati, OH
Related Studies
- Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHDPHASE4 · Recruiting · Icahn School of Medicine at Mount Sinai · Gainesville, Florida
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual DisabilitiesPHASE1 · Enrolling By Invitation · University of California, Davis · Sacramento, California
- ADHD PreSMA Response Inhibition TherapyRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio